Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. by Plein, S. et al.
CURRENT OPINION
Training and accreditation in cardiovascular
magnetic resonance in Europe: a position
statement of the working group on
cardiovascular magnetic resonance of the
European Society of Cardiology
Sven Plein1,2*, Jeanette Schulz-Menger3, Ana Almeida4, Heiko Mahrholdt5,
Frank Rademakers6, Dudley Pennell 7, Eike Nagel2, Juerg Schwitter8, and
Massimo Lombardi9, on behalf of the Working Group on Cardiovascular Magnetic
Resonance of the European Society of Cardiology
1Division of Cardiovascular and Neuronal Remodelling, Leeds Multidisciplinary Cardiovascular Research Centre, LIGHT Laboratories, University of Leeds, G-floor, Jubilee Wing, Leeds
General Infirmary, Great George Street, Leeds LS1 3EX, UK; 2BHF Centre of Excellence, NIHR Biomedical Research Centre, Division of Imaging Sciences, King’s College London, The
Rayne Institute, St Thomas’ Campus, UK; 3Charite´ Campus Buch, University Medicine Berlin, HELIOS Klinikum Berlin-Buch, Germany; 4Servic¸o de Cardiologia, Hospital de Santa Maria,
Lisboa, Portugal; 5Department of Cardiology, Robert Bosch Medical Centre, Stuttgart, Germany; 6Division of Imaging and Cardiovascular Dynamics, K.U. Leuven, Belgium; 7National
Heart and Lung Institute, London, UK; 8Cardiac MR Centre, University Hospital Lausanne, Lausanne, Switzerland; and 9MRI Laboratory CNR, Institute of Clinical Physiology, Pisa, Italy
Received 12 March 2010; revised 19 October 2010; accepted 2 December 2010; online publish-ahead-of-print 2 February 2011
Background
Cardiovascular magnetic resonance (CMR) has become an estab-
lished imaging modality which provides often unique information
on a wide range of cardiovascular diseases. The European
Society of Cardiology (ESC) training curriculum reflects the emer-
ging role of CMR by recommending that all trainees obtain a
minimum level of training in CMR and by defining criteria for sub-
specialty training in CMR.1 The wider use of CMR requires the
definition of standards for data acquisition, reporting, and training
in CMR across Europe. At the same time, training and accreditation
in all cardiac imaging methods should be harmonized and inte-
grated to promote the training of cardiac imaging specialists. The
recommendations presented in this document are intended to
inform the discussion about standards for accreditation and certi-
fication in CMR in Europe and the discussion on integrated imaging
training. At present, the recommendations in this position state-
ment are not to be interpreted as guidelines. Until such guidelines
are available and nationally ratified, physicians will be able to train
and practice CMR according to current national regulations.
Aims
This document has been prepared by the working group (WG) on
CMR of the ESC. It aims to make proposals for a European
standard for competency and excellence in CMR acquisition and
reporting. This is to be achieved by providing recommendations
for training of individuals wishing to perform and report CMR
studies as well as for the accreditation of centres performing
CMR studies and wishing to offer CMR training. The document
has been written in concordance with the ESC processes on
accreditation and certification. However, it is emphasized that
European certification of CMR competency or institutional accred-
itation in CMR as outlined in this document are not compulsory or
regulatory certificates. An individual’s right to report and sign clini-
cal studies and an institution’s right to provide a CMR service in
individual countries remain defined by National laws and
regulations.
These processes have been synchronized as much as possible
with other recommendations for CMR training such as the Core
Cardiology Curriculum of the ESC,1 those guidelines of the
Society for Cardiovascular Magnetic Resonance (SCMR),2 and
the European Association of Echocardiography.3
The WG recognizes that physicians who have completed their
specialty training and hold a licence to practice medicine face
different constraints than trainees and it will often be impractical
for them to spend prolonged periods away from their place of
work. These recommendations therefore include alternative train-
ing options for licensed physicians.
* Corresponding author. Tel +44 113 3925404, Fax +44 113 3925405, Email: s.plein@leeds.ac.uk
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2011. For permissions please email: journals.permissions@oup.com
European Heart Journal (2011) 32, 793–798
doi:10.1093/eurheartj/ehq474
Individual certification
Who benefits from obtaining European
certification of cardiovascular magnetic
resonance competency?
† The goal of certifying individuals is to set a European standard
for competency and excellence in CMR acquisition and
reporting.
† Certification in CMR will bring credibility and professional legiti-
macy to an individual wishing to practice CMR.
† Certification of competency in CMR can be obtained at three
levels, reflecting the different training needs between general
cardiologists and those with a subspecialty interest in imaging;
† Level 1 competency is the most basic level and reflects core
CMR training that should be obtained by all cardiology trai-
nees according to the ESC Core Cardiology Curriculum.
† Level 2 competency is the level required for an individual
wishing to report CMR studies—with local or remote
support from a Level 3 certified individual. Certification of
Level 2 competency fulfils the requirement of sub-specialty
training in cardiac imaging as set out in the ESC curricula.
† Level 3 competency is required for individuals wishing to
perform, interpret, and report CMR studies fully indepen-
dently, to lead a CMR laboratory and to supervise CMR train-
ing programmes in an accredited CMR training centre.
† European certification of CMR competency is not a compulsory
or regulatory certificate. At present, an individual’s right to
report and sign clinical studies in individual countries are
defined by National laws and regulations.
Requirements for cardiovascular
magnetic resonance competency
Level 1
Level 1 competency in CMR is a core component of the Cardiol-
ogy Curriculum of the ESC.1 This level of competency represents
basic background knowledge in CMR sufficient to select the appro-
priate CMR indications for patients with known or suspected car-
diovascular diseases and interpret CMR reports in the clinical
context. Level 1 competency is not sufficient for the practice or
independent clinical interpretation of CMR. The WG recommends
that Level 1 competency in CMR requires:
(a) A documented involvement in 50 CMR cases and a full-time
attachment of 1 month (or the equivalent distributed over
up to 6 months) to an accredited CMR institution or under
the guidance of a Level 3 accredited CMR expert. For phys-
icians who hold specialty certification, a more flexible training
plan can be agreed between the trainer and the candidate. This
should contain a minimum of 2 weeks on site training and can
include up to 2 weeks remote training. The use of training
databases or case-study collections is encouraged.
(b) Attendance to departmental or other teaching events to
understand basic CMR physics and clinical use of CMR,
common protocols, costs, artefacts, indications, contraindica-
tions, and pitfalls (20 CME hours). See Appendix 1 for
required course topics.
Level 2
Certification of Level 2 competency in CMR is aimed at individuals
who wish to sub-specialize in cardiac imaging and who want to
actively perform and report CMR under the supervision of a
Level 3 accredited expert. The supervising Level 3 expert must
either work in the same institution or offer remote support for
all aspects related to CMR scanning and reporting. The WG rec-
ommends that Level 2 certification should only be issued after
completion of specialty training and that the formal certification
process consists of three parts, which must all be completed:
(a) Lectures and courses: course work to include more advanced
lectures and reading materials than for Level 1 and to continue
for the duration of the traineeship (at least 50 CME hours).
Training must also include at least one organized CMR teach-
ing course.
(b) Training in an accredited centre: Level 2 certification can be
acquired in a minimum of 3 months spent in an accredited
institution under the guidance of a Level 3 accredited CMR
expert. Training does not have to be consecutive, but has to
fall within a 2-year period. All candidates must submit a
logbook of 150 clinical cases.
(c) Written exam: candidates must pass the European CMR exam.
(a) Lectures and courses. Level 2 certification should include formal
teaching events to understand basic CMR physics and clinical use of
CMR, common protocols, costs, artefacts, indications, contraindi-
cations, and pitfalls. All ESC-endorsed CMR teaching courses,
which cover the physics and clinical application of CMR (such as
the course organized by the WG, www.CMR-course.de), or
other courses or training programmes that provide at least 50 h
of CME in CMR are recognized for this purpose. For rec-
ommended course topics see Appendix 1.
(b) Training in an accredited centre. Candidates should prepare a log
book consisting of 150 anonymized CMR studies accrued over a
12-month period (from 1 year before until 1 year after passing
the written exam). The candidate should have been present
during the acquisition of at least 50 of the cases. At least 50
studies should be primarily reported by the candidate. The log
book should be written in English.
The following categories of pathology/clinical assessment should
be included in the log book:
† detection of myocardial infarction and assessment of viability;
† stress testing with either vasodilator or staged inotropic stress
(at least 25 cases);
† left and right ventricular function assessment;
† aortic, mitral, tricuspid, and pulmonary valve pathology;
† aortic pathology including dilatation and dissection;
† common basic congenital heart disease (CHD) and adult CHD
(ACHD) (such as coarctation of the aorta, post-operative
Tetralogy of Fallot, intracardiac shunts, coronary anomalies)
(at least 25 cases);
† assessment of causation of heart failure;
† assessment of cardiomyopathy phenotype including hypertrophic
cardiomyopathy, arrhythmogenic right ventricular cardiomyo-
pathy, dilated cardiomyopathy;
† pericardial abnormality;
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† cardiac mass/tumour;
† angiography of major arteries including aorta, pulmonary,
carotid, and renal.
Where not all of these indications can be obtained in a particular
training centre, the candidate should endeavour to receive specific
training in another accredited centre. If this cannot be achieved,
cases or teaching files from other centres can be used—but not
for more than 100 cases.
Teaching must take place in an accredited CMR Institution (see
Aims section). However, the WG recognizes that institutional
accreditation is a new concept, and recommends that for an
interim period training under the auspices of a Level 3 accredited
individual in a non-accredited institution is accepted.
Because many CMR studies are performed during pharmaco-
logical stress, the WG regards it as an essential requirement of
CMR accreditation that an individual wishing to supervise CMR
studies is trained in Basic Cardio-Pulmonary life support (BCLS)
and Advanced Cardio-Pulmonary life support (ACLS). This can
be obtained from any accredited ACLS training centre, often
within the host institution or can be part of a clinical training
programme.
Documents to submit with the log book:
† Summary sheet.
† Letter from a supervisor testifying that the studies were per-
formed and reported by the candidate.
† Letter from the supervisor documenting training and the review
of studies undertaken by the candidate.
† Supervisor enrolment form.
† BCLS and ACLS documentation.
† Copies of relevant board certifications and licences.
(c) The written exam. A written exam is to be held under the
auspices of an independent ESC-appointed authority. The exam
consists of a theoretical and a clinical case reporting part. Both
parts of the examination have to be passed to be successful in
the examination. If Level 2 accreditation has not been achieved
within 5 years of taking the examination, the exam has to be
repeated.
Re-certification
It is recommended that following certification, Level 2 accredited
individuals maintain their skills by documentation of at least 20 h
of CME in CMR every 3 years plus the documented attendance
during and the primary reporting of at least 100 CMR studies
every 3 years. These cases may not be taken from a database.
Level 3
Certification of Level 3 CMR competency represents the highest
level of expertise and would enable an individual to pursue a clini-
cal or academic career in CMR, to direct a CMR laboratory and
act as an accredited CMR trainer in an accredited CMR training
centre. In addition to the recommendation for Level 2, Level 3
competency should reflect more in-depth and structured training
and supervised interpretation of at least 300 CMR cases. As for
level 2, the WG recommends certification should only be
issued after completion of specialty training and that the formal
certification process consists of three parts, which must all be
completed:
(a) Lectures and courses: at least 50 CME hours over no more
than 2 years including at least one organized CMR teaching
course.
(b) Training in an accredited centre: Level 3 certification can be
acquired over a 12-month period with a log book of 300 clini-
cal cases.
(c) Written exam: candidates must pass the European CMR exam.
(a) Lectures and courses. At least 50 CME accredited hours of CMR
training should be attended within a period of 2 years. In addition,
training in the accrediting centre should include a structured teach-
ing programme covering in detail MR physics, clinical indications,
and image interpretation. See Appendix 1 for recommended
course topics. Training must also include at least one organized
CMR teaching course.
(b) Training in an accredited centre. For Level 3 certification, candi-
dates should keep a log book consisting of 300 anonymized
CMR studies accrued over a 12-month period (from 1 year
before until 1 year after passing the written exam). The candidate
should have been present during the scan and be involved in the
acquisition and the primary interpretation of at least 100 CMR
cases. In the remaining 200 cases, the trainee should review at
least 100 of these cases with the Level 3 mentor. The log book
should be written in English.
The following categories of pathology/clinical assessment should
be included in the log book:
† detection of myocardial infarction and assessment of viability;
† stress testing with either vasodilator or staged inotropic stress
(at least 50);
† left and right ventricular function assessment;
† aortic, mitral, tricuspid, and pulmonary valve pathology;
† aortic pathology including dilatation and dissection;
† common basic CHD and ACHD (such as coarctation of the
aorta, post-operative Tetralogy of Fallot, intracardiac shunts,
coronary anomalies) (at least 50 cases);
† assessment of causation of heart failure;
† assessment of cardiomyopathy phenotype including hyper-
trophic cardiomyopathy, arrhythmogenic right ventricular cardi-
omyopathy, dilated cardiomyopathy;
† pericardial abnormality;
† cardiac mass/tumour;
† angiography of major arteries including aorta, pulmonary,
carotid, and renal.
Where not all of these indications can be obtained in a particular
training centre, the candidate should endeavour to receive specific
training in another accredited centre. If this cannot be achieved,
cases or teaching files from other centres can be used, but not
for more than 200 cases.
Teaching must take place in an accredited CMR Institution (see
Aims section). However, the WG recognizes that institutional
accreditation is a new concept, and recommends that for an
interim period, training under the auspices of a Level 3 accredited
individual in a non-accredited institution is accepted.
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Because many CMR studies are performed during pharmaco-
logical stress, the WG regards it as an essential requirement
of CMR accreditation that an individual wishing to supervise
CMR studies is trained in BCLS and ACLS. This can be
obtained from any accredited ACLS training centre, often
within the host institution or can be part of a clinical training
programme.
It is expected that the individual participates in an ongoing
quality assurance or improvement programme for the laboratory
or facility in which he or she is associated.
Documents to submit with the log book:
† Summary sheet.
† Letter from a supervisor testifying that the studies were per-
formed and reported by the candidate.
† Letter from the supervisor documenting training and the review
of studies undertaken by the candidate.
† Supervisor enrolment form.
† Basic and Advanced Cardiac Life Support documentation.
† Copies of relevant board certifications and licences.
† Evidence of participation in a quality assurance or improvement
programme.
(c) The written exam. The CMR exam is mandatory for Level 3.
If it has been passed as part of Level 2 certification, the exam
does not need to be repeated to obtain Level 3 accreditation. If
an individual applies directly for Level 3 certification without pre-
ceding Level 2 certification, the exam is mandatory and Level 3
accreditation must be achieved within 5 years of taking the
examination.
Re-certification
It is recommended that following certification, Level 3 accredited
individuals maintain their skills by documentation of at least 40 h
of CME in CMR every 3 years plus the acquisition and primary
reporting of at least 200 CMR studies every 3 years. These cases
cannot be taken from a database. It is also recommended that
they participate in an active training programme either in their
own institution or by contribution to national or international edu-
cational activities in CMR.
Table 1 summarizes the training requirements for the three
levels of certification.
Training in cardiovascular magnetic
resonance of congenital and adult
congenital heart disease
The WG considers CMR in CHD and ACHD to be subspecialty
qualifications beyond the scope of this document. This view is
consistent with recommendations by other ESC WGs and
associations.4,5 However, all individuals seeking training in CMR
need to be aware of the common indications of CMR in CHD
and ACHD. In addition, Level 2 and Level 3 training in CMR
must include exposure to some CMR studies in CHD and
ACHD so that trained individuals can recognize these conditions
and refer to a specialist if required. The WG considers 25 (for
Level 2) or 50 (for Level 3) to be the minimal number of
cases required.
Institutional accreditation
The aim of institutional accreditation in CMR is to harmonize stan-
dards across the European Community and to ensure the quality of
training in CMR. The difficulties associated with accrediting insti-
tutions for CMR are recognized but the WG firmly expects that
this process is necessary to maintain standards during the expected
expansion of CMR services across Europe. The proposals for an
accreditation process links with other core initiatives of the WG,
in particular individual certification and the EuroCMR registry.
The proposals for institutional accreditation set out in this docu-
ment should be achievable by most institutions performing CMR
on a regular basis.
Which institutions will benefit from
obtaining European cardiovascular
magnetic resonance accreditation?
† The goals of institutional accreditation are to set a European
standard for the practice of CMR and for the institutional train-
ing of individuals in CMR.
† European CMR accreditation will bring credibility and legitimacy
to an institution wishing to perform CMR studies and to train
individuals in CMR and demonstrates commitment to quality
care.
† In an increasingly competitive environment, site accreditation
will give an advantage to institutions in negotiations with
health care funders.
† Accreditation can be linked to the EuroCMR registry, giving the
opportunity for confidential peer-review and quality control.
† Accreditation in CMR for institutions is not a compulsory or
regulatory certificate of competence or excellence and does
not cover any aspects of MR safety. At present, all of these
remain to be defined by National laws and regulations.
† SCMR accredited sites can apply for automatic European CMR
accreditation at no additional cost.
Requirements
Institutional accreditation in CMR should include the following:
(a) Case load: institutions need to perform at least 400 CMR
studies per year.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Summary of recommendations for individual
certification in cardiovascular magnetic resonance
Level Duration of
training
Cases CMR
exam
CME
(h)
Other
1 1 month 50+ No 20
2 3 months
(can be split)
150+ (log book) Yes 50 BCLS,
ACLS
3 12 months
(can be split)
300+ (log book) Yes 50 BCLS,
ACLS
BCLS, Basic Cardiac Life Support; ACLS, Advanced Cardiac Life Support.
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(b) Case mix: a wide case mix has to be covered at the institution,
following the recommendations for the log book for individual
accreditation.
(c) Supervision: the institution is led by qualified supervisors (ESC
Level 3, SCMR Level 3, or equivalent national accreditation).
Clinical cases are reviewed with trainees in a regular scheduled
reporting session.
(d) Structured training programme: regular audit and teaching is
provided (at least one scheduled teaching session per week).
Teaching covers all aspects of CMR, including Physics and prac-
tical scanning.
(e) Safety of CMR studies: because of the general increase in
referrals for CMR studies requiring pharmacological stress,
the WG regards it as essential that accredited CMR sites
demonstrate they have procedures in place to respond
rapidly and appropriately to common cardiovascular emergen-
cies such as cardiac arrhythmia, cardiogenic shock, and respir-
atory failure. This recommendation is in accordance with the
guidelines for stress echocardiography by the European
Association for Echocardiography.6 Institutions need to show
that;
† They have standard operating procedures in place for the
safe and rapid removal of patients from the magnet into
an appropriate resuscitation area (the WG recommends
that this takes no more than 1 min).
† They have the necessary equipment to deal with common
emergencies (including specifically an external cardiac defi-
brillator, emergency drugs, high flow oxygen, and intubation
instrumentation).
† Evacuation and resuscitation procedures are rehearsed at
least every 6 months and that new members of staff are
trained before they can actively participate in stress studies.
† Staff performing CMR studies is trained in ACLS and that
trained personnel is present in the department during
studies involving pharmacological stress.
(f) MR safety: the WG recognizes that there is currently no
Europe-wide guideline on requirements for the safe operation
of magnetic resonance facilities. Such guidelines are in prep-
aration and once available will become a requirement for
site accreditation. In the meantime, the WG recommends
that sites demonstrate compliance with local or national
safety guidance.
(g) Quality-control: it is recommended that the institution par-
takes in a peer-reviewed quality programme [such as the
EuroCMR registry: www.herzinfarktforschung.de/Projekte/
RegisterI/EuroCMR.html)]. We anticipate that participation in
a formal quality control programme will become a mandatory
requirement for site accreditation in the future.
(h) Multi-modality imaging environment: the WG on CMR
appreciates that CMR will in most institutions be available
along with several other cardiovascular imaging modalities
including echocardiography, invasive angiography, nuclear
cardiology, cardiac computed tomography, and others.
The structure and interaction of such multimodality
imaging facilities need to be defined separately in future
joint documents.
Institutional accreditation for
cardiovascular magnetic resonance of
congenital and adult congenital heart
disease
The WG on CMR considers accreditation of institutions for CMR
in CHD and ACHD to be outside the scope of this document.
Consistent with recommendations by other ESC WGs and associ-
ations,4,5 centres wishing to perform these studies on a regular
basis require subspecialty accreditation that is to be defined separ-
ately. However, all institutions seeking accreditation in CMR should
demonstrate that common indications of CMR in CHD and ACHD
can be recognized in the centre and are appropriately referred to a
specialist centre if required.
Accreditation process
The following documents should be part of a request for site
accreditation:
† Level 3 CMR certificate for at least one member of the
institution.
† An outline of the CMR and multi-modality cardiovascular
imaging training programme.
† A scan log of 400 cases performed in the previous 12 months.
† Standard operating procedures for dealing with cardiovascular
emergencies.
† Demonstration of compliance with local or national MR safety
guidelines.
† Recommended: demonstration of participation in a quality
control programme.
Appendix 1
Topics for course work
Level 1
The trainee should develop a basic understanding of:
(1) MR physics:
(a) the basics of physics of magnetic resonance as it relates to
image intensity and contrast, including flow, T1, T2, density
of nuclear species (e.g. proton), and contrast agents;
(b) the principles of common CMR methods, including cine
imaging, velocity encoded CMR, black blood imaging,
dynamic and late contrast enhanced imaging, and MR
angiography.
(2) Clinical use of CMR:
(a) clinical indications for CMR and the role of CMR com-
pared with other imaging modalities;
(b) contraindications to CMR and safety issues, including
safety of implanted devices (e.g. pacemakers, automatic
implantable cardioverter-defibrillators), external ferro-
magnetic devices, and gadolinium-based contrast agents;
(c) Basic CMR protocols for common clinical indications;
(d) basic post-processing approaches and analyses.
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Level 2
The above plus
(1) Physics: trainees should receive didactic lectures from a
CMR-trained physician (who has achieved Level 2 or 3 in
CMR) and/or physicist on the basic physics of magnetic reson-
ance in general and as it relates to CMR in particular. The
content should include the same materials as in Level 1
(basic) plus lectures with supportive reading on the following
topics:
(a) Image formation, including k-space, gradient echo, spin
echo, fast spin echo, echo planar, spiral, steady state free
precession (SSFP), and parallel imaging;
(b) Specialized imaging sequences, including flow and motion,
phase imaging, time of flight, contrast agents, and radiofre-
quency tagging;
(c) Hardware components, including the elements of gradient
coil design, receiver coils, and digital sampling;
(d) Sources of artefacts, including motion, arrhythmias, and
metal objects.
(2) Applications, interpretation, indications, and contraindications:
Level 2 didactic activities should include an understanding of
the sensitivity, specificity, accuracy, utility, costs, acquisition
approaches, and disadvantages of all of the contemporary
techniques in CMR. The following techniques should be
covered in the didactic program:
(a) Imaging of structure and tissue characterization (T1, T2,
spin echo, gradient echo, SSFP, image contrast mechan-
isms, and fat suppression);
(b) Imaging and analysis of cardiac function (cine and tagged
cine magnetic resonance including SSFP imaging
approaches);
(c) Volumetric imaging and measurement of mass, biventricu-
lar volumes, and ejection fraction (using cine magnetic res-
onance imaging);
(d) Flow imaging (e.g. velocity-encoded techniques) and analy-
sis of flow-encoded images;
(e) Imaging of myocardial infarction, scarring, and viability
assessment (delayed contrast-enhancement imaging);
(f) Pharmacologic stress testing with evaluation of ventricular
function and/or first-pass perfusion imaging using a con-
trast agent;
(g) Magnetic resonance angiography (vascular);
(h) Imaging of the coronary arteries and classification of cor-
onary anomalies;
(i) Imaging of valve pathology;
( j) CMR assessment of aortic pathology;
(k) Common basic CHD and ACHD (such as coarctation of
the aorta, post-operative Tetralogy of Fallot, intracardiac
shunts, coronary anomalies);
(l) CMR imaging in heart failure.
(m) CMR assessment of cardiomyopathy phenotype including
hypertrophic cardiomyopathy, arrhythmogenic right ven-
tricular cardiomyopathy, dilated cardiomyopathy;
(n) Imaging of the pericardium with common pathologies;
(o) Assessment of cardiac masses and tumours;
(p) Mechanisms, types, and pharmacologic aspects of CMR
contrast agents;
(q) Electrocardiogram and peripheral pulse gating and trigger-
ing including timing of image acquisition within the R–R
interval, motion artefacts, and their effects on CMR
images; respiratory motion suppression methods (e.g.
breath-holding and navigators);
(r) CMR image analysis and post-processing tools;
(s) Contraindications for CMR study;
(t) Incidental findings suggesting pathology outside of the car-
diovascular system.
Level 3
The above plus
(1) An understanding of why certain specialized imaging sequences
are applicable for specific clinical protocols, including imaging
of heart function, coronary arteries, perfusion, delayed
enhancement, and peripheral arteries.
(2) Basic understanding of the clinically applicable spectroscopic
methods.
(3) The essentials of data collection, including capturing of digital
data, the maintenance of accurate databases and records,
signal processing, and the approaches for quantitative data
analysis.
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